+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Solid Tumor"

Oncology Based In-vivo CRO Market Size, Share & Trends Analysis Report By Indication (Blood Cancer, Solid Tumor), By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Oncology Based In-vivo CRO Market Size, Share & Trends Analysis Report By Indication (Blood Cancer, Solid Tumor), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • January 2023
  • 100 Pages
  • Global
From
Global Immuno-oncology Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Design (Interventional Trials, Observational Trials), by Indication, by Region, and Segment Forecasts, 2021-2028 - Product Thumbnail Image

Global Immuno-oncology Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Design (Interventional Trials, Observational Trials), by Indication, by Region, and Segment Forecasts, 2021-2028

  • Report
  • June 2021
  • 100 Pages
  • Global
From
Flow Cytometry in Oncology Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F - Product Thumbnail Image

Flow Cytometry in Oncology Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

  • Report
  • April 2024
  • 185 Pages
From
Oncology Based in-Vivo CRO Market - Growth, Trends, and Forecasts (2023-2028) - Product Thumbnail Image

Oncology Based in-Vivo CRO Market - Growth, Trends, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 120 Pages
  • Global
From
Oncology Precision Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 By Ecosystem, By Application and By Region - Product Thumbnail Image

Oncology Precision Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 By Ecosystem, By Application and By Region

  • Report
  • November 2022
  • 111 Pages
  • Global
From
Head and Neck Cancer (HNC) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Head and Neck Cancer (HNC) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • September 2022
  • 239 Pages
  • Global
From
Market Spotlight: Small-Cell Lung Cancer (SCLC) - Product Thumbnail Image

Market Spotlight: Small-Cell Lung Cancer (SCLC)

  • Report
  • November 2020
  • 49 Pages
  • Global
Market Spotlight: Esophageal Cancer (2020) - Product Thumbnail Image

Market Spotlight: Esophageal Cancer (2020)

  • Report
  • March 2020
  • 42 Pages
  • Global
Disease Analysis: Gastric Cancer - Product Thumbnail Image

Disease Analysis: Gastric Cancer

  • Report
  • June 2021
  • 88 Pages
  • Global
Disease Analysis: Non-Small Cell Lung Cancer (NSCLC) - Product Thumbnail Image

Disease Analysis: Non-Small Cell Lung Cancer (NSCLC)

  • Report
  • April 2021
  • 191 Pages
  • Global
Gene Therapy in Oncology - Thematic Research - Product Thumbnail Image

Gene Therapy in Oncology - Thematic Research

  • Report
  • June 2021
  • Global
From
Squamous-Cell Carcinoma of the Pharynx and Oral Cavity in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard - Product Thumbnail Image

Squamous-Cell Carcinoma of the Pharynx and Oral Cavity in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard

  • Report
  • June 2023
  • 48 Pages
  • United States
From
Squamous-Cell Carcinoma of the Pharynx and Overlapping Areas in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard - Product Thumbnail Image

Squamous-Cell Carcinoma of the Pharynx and Overlapping Areas in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard

  • Report
  • June 2023
  • 48 Pages
  • United States
From
Squamous-Cell Carcinoma of the Head and Neck in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard - Product Thumbnail Image

Squamous-Cell Carcinoma of the Head and Neck in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard

  • Report
  • June 2023
  • 48 Pages
  • United States
From
Gastric Adenocarcinoma in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard - Product Thumbnail Image

Gastric Adenocarcinoma in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard

  • Report
  • June 2023
  • 48 Pages
  • United States
From
Squamous-Cell Carcinoma of the Esophagus in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard - Product Thumbnail Image

Squamous-Cell Carcinoma of the Esophagus in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard

  • Report
  • June 2023
  • 48 Pages
  • United States
From
Esophageal Cancer in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard - Product Thumbnail Image

Esophageal Cancer in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard

  • Report
  • June 2023
  • 48 Pages
  • United States
From
Gastroesophageal Cancer in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard - Product Thumbnail Image

Gastroesophageal Cancer in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard

  • Report
  • June 2023
  • 48 Pages
  • United States
From
Gastroesophageal Adenocarcinoma in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard - Product Thumbnail Image

Gastroesophageal Adenocarcinoma in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard

  • Report
  • June 2023
  • 48 Pages
  • United States
From
Adenocarcinoma of the Esophagus in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard - Product Thumbnail Image

Adenocarcinoma of the Esophagus in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard

  • Report
  • June 2023
  • 48 Pages
  • United States
From
Loading Indicator

The Solid Tumor market within the context of Oncology is a highly competitive and rapidly evolving field. It is focused on the development of treatments for solid tumors, which are malignant tumors that form in the body's organs and tissues. These tumors can be caused by a variety of factors, including genetic mutations, environmental exposures, and lifestyle choices. Treatment options for solid tumors include surgery, chemotherapy, radiation therapy, and targeted therapies. The Solid Tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. Companies in this market are focused on developing innovative treatments and therapies to improve patient outcomes. Examples of companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more